NuVasive Inc $35.10

up +0.20


29/8/2014 04:00 PM  |  NASDAQ : NUVA  
Industries : Health Services / Medical Appliances & Equipment
Get Trend Analysis Icon Get NUVA Trend Analysis - it has outperformed the S&P 500 by 26%

Partner Headlines

  1. Fellow orthopedics maker

    IBD
  2. Zimmer To Acquire Biomet; Stock Soars

    IBD
  3. NuVasive Announces $30M Unfavorable Jury Verdict for Use of Trade-Name ...

    Benzinga
  4. NuVasive Up After Q4 Beat, Despite Cautious Guidance

    IBD
  5. Ukraine Unrest Sparks Selling But Some Biotechs Firm Up

    IBD
  6. Earnings Scheduled For March 3, 2014

    Benzinga
  7. Stocks Hitting 52-Week Highs

    Benzinga
  8. NuVasive pops to 3-year high

    IBD
  9. Mid-Afternoon Market Update: Markets Nearly Erase Early Year Losses as ...

    Benzinga
  10. Mid-Day Market Update: Dow Jumps 120 Points; Fastenal Shares Drop On Downbeat ...

    Benzinga
  11. NuVasive Preliminary Q4 Sales Beat, Stock Jumps

    IBD
  12. Mid-Morning Market Update: Markets Rise; Bank of America Profit Beats Estimates

    Benzinga
  13. Benzinga's Volume Movers

    Benzinga
  14. Stocks Hitting 52-Week Highs

    Benzinga
  15. UPDATE: Goldman Sachs Downgrades NuVasive as Industry Headwinds, Valuation ...

    Benzinga
  16. Benzinga's Top Downgrades

    Benzinga
  17. Benzinga's Top Initiations

    Benzinga
  18. Market Wrap For Wednesday, July 31: Stocks Mostly Unchanged Despite Upbeat ...

    Benzinga
  19. Mid-Afternoon Market Update: Fed Leaves Rates Unchanged; Green Dot Rises

    Benzinga
  20. Mid-Afternoon Market Update: NuVasive Rises While EXCO Resourced Drops

    Benzinga
  21. Mid-Day Market Update: Markets Remain Up, Dynavax Continues Rally

    Benzinga
  22. Benzinga's Top Upgrades

    Benzinga
  23. NuVasive Announces First Patient in the United States Treated With the ...

    Benzinga
  24. NuVasive(R) Announces Release of $62.5M From Escrow Following Appeals Court ...

    Benzinga
  25. NuVasive to Release $62.5M from Escrow Following Appeals Court Win

    Benzinga
  26. Covidien Stock Rises After Earnings Beat Estimates

    IBD
  27. NuVasive Announces PMA Approval of the PCM(R) Cervical Disc System

    Benzinga
  28. NuVasive Inc. Reports Operating Results (10-Q)

    GuruFocus
  29. Benzinga's Top Downgrades

    Benzinga
  30. UPDATE: Goldman Sachs Reduces PT to $16 on NuVasive on Sales Outlook

    Benzinga
  31. Intuitive Surgical Stock Rebounds From Q3 Dive

    IBD
  32. Intuitive Surgical Stock Upgraded Ahead Of Q3 Report

    IBD
  33. FDA Ruling on Artificial Disc Boosts Globus Medical

    IBD
  34. The Hell With NuVasive Stock: Get Hired by One of its Competitors at $1M

    YCharts
  35. Stocks Post Gains after Positive Data with Bank of America (BAC) and Alcoa ...

    MarketIntelligenceCenter
  36. Nuvasive (NUVA) Drops 33% on Weak Q3 Revenue

    MarketIntelligenceCenter
  37. Benzinga Mid-Afternoon Market Update

    Benzinga
  38. Stock Futures Point to Higher Open Ahead of Data with Facebook (FB) and ...

    MarketIntelligenceCenter
  39. UPDATE: BMO Capital Markets Downgrades NuVasive to Underperform on Outlook

    Benzinga
  40. Benzinga Mid-Morning Market Update

    Benzinga
  41. US Stock Futures Up; Jobless Claims, ECB Meeting In Focus

    Benzinga
  42. Stocks To Watch For October 4, 2012

    Benzinga
  43. Nuvasive

    IBD
  44. NuVasive Cuts Q3 Prelim Revenue, Forecast $147M

    Benzinga
  45. NuVasive Inc. Reports Operating Results (10-Q)

    GuruFocus
  46. Medtronic, Snyder's-Lance and Other Stocks Insiders Are Buying

    Benzinga
  47. Analyst Upgrades: NUVA, ONXX, and SKUL

    SchaeffersResearch
  48. Analyst Upgrades: NUVA, QCOM, and SPWR

    SchaeffersResearch
  49. NuVasive Up 20% After Q1 Earnings

    Benzinga
  50. NuVasive Inc. Reports Operating Results (10-K)

    GuruFocus
Trading Center